Concern contractors left ‘out of pocket’ with new levothyroxine advice
New MHRA guidance about prescribing levothyroxine could leave contractors with the choice of being “out of pocket” or face telling prescribers to re-issue scripts, pharmacists say.
According to a Medicines and Healthcare products Regulation Agency (MHRA) guidance update on levothyroxineissued last week (May 19), healthcare professionals should “consider consistently prescribing
What do you make of the new levothyroxine prescribing guidance?